{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:20:13Z","timestamp":1793733613363,"version":"4.6.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1053\/j.seminhematol.2022.07.004","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T02:05:46Z","timestamp":1659492346000},"page":"123-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The spectrum of somatic mutations in large granular lymphocyte leukemia, rheumatoid arthritis, and Felty's syndrome"],"prefix":"10.1053","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6254-0905","authenticated-orcid":false,"given":"Paula","family":"Savola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipabarna","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jani","family":"Huuhtanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2022.07.004_bib0001","doi-asserted-by":"crossref","first-page":"9846","DOI":"10.1073\/pnas.1607794113","article-title":"Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing","volume":"113","author":"Hoang","year":"2016","journal-title":"Proc Natl Acad Sci"},{"issue":"80-","key":"10.1053\/j.seminhematol.2022.07.004_bib0002","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aaa6806","article-title":"High burden and pervasive positive selection of somatic mutations in normal human skin","volume":"348","author":"Martincorena","year":"2015","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0003","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41467-018-03244-6","article-title":"Somatic mutagenesis in satellite cells associates with human skeletal muscle aging","volume":"9","author":"Franco","year":"2018","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0004","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ng.2413","article-title":"Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis","volume":"44","author":"Busque","year":"2012","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0006","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev-physiol-061121-040048","article-title":"Somatic mosaicism in biology and disease","volume":"84","author":"Ogawa","year":"2022","journal-title":"Annu Rev Physiol"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0007","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra2101920","article-title":"Somatic mutations in \u201cBenign\u201d disease","volume":"384","author":"Mustjoki","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0008","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1709449","article-title":"Somatic activating KRAS mutations in arteriovenous malformations of the brain","volume":"378","author":"Nikolaev","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0009","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1172\/JCI78088","article-title":"Mechanisms of human autoimmunity","volume":"125","author":"Rosenblum","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0010","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1172\/JCI200114235","article-title":"Mechanisms for the induction of autoimmunity by infectious agents","volume":"108","author":"Wucherpfennig","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0011","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/10428194.2017.1339880","article-title":"Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL)","volume":"59","author":"Sanikommu","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0012","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.blre.2014.02.001","article-title":"The pathogenesis and treatment of large granular lymphocyte leukemia","volume":"28","author":"Steinway","year":"2014","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0013","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3324\/haematol.2009.018481","article-title":"Analysis of a French cohort of patients with large granular lymphocyte leukemia: A report on 229 cases","volume":"95","author":"Bareau","year":"2010","journal-title":"Hematologica"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0014","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1200\/EDBK_200689","article-title":"Latest advances in the diagnosis and treatment of large granular lymphocytic leukemia","volume":"38","author":"Moignet","year":"2018","journal-title":"Am Soc Clin Oncol Educ B"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1634\/theoncologist.11-3-263","article-title":"Large granular lymphocyte leukemia","volume":"11","author":"Sokol","year":"2006","journal-title":"Oncologist"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0016","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","article-title":"LGL leukemia: from pathogenesis to treatment","volume":"129","author":"Lamy","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0017","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41375-019-0644-0","article-title":"Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients","volume":"34","author":"Baril\u00e0","year":"2020","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2022.869205","article-title":"Intersection between large granular lymphocyte leukemia and rheumatoid arthritis","volume":"12","author":"Moosic","year":"2022","journal-title":"Front Oncol"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0019","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0002-9343(89)90300-8","article-title":"Prevalence of granular lymphocyte proliferation in patients with rheumatoid arthritis and neutropenia","volume":"86","author":"Saway","year":"1989","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0021","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.berh.2004.05.002","article-title":"Felty's syndrome","volume":"18","author":"Balint","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0022","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/art.1780370909","article-title":"The large granular lymphocyte syndrome with rheumatoid arthritis. Immunogenetic evidence for a broader definition of Felty's syndrome","volume":"37","author":"Bowman","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0023","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005792-199069020-00001","article-title":"The felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations","volume":"69","author":"Campion","year":"1990","journal-title":"Med"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0024","first-page":"16","article-title":"Chronic arthritis in the adult associated with splenomegaly and leucopenia","volume":"35","author":"Felty","year":"1924","journal-title":"Bull Johns Hopkins Hosp"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0025","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clml.2012.06.006","article-title":"Autoimmune manifestations in large granular lymphocyte leukemia","volume":"12","author":"Bockorny","year":"2012","journal-title":"Clin Lymphoma, Myeloma Leuk"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0026","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-102-2-169","article-title":"Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia","volume":"102","author":"Loughran","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0027","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/art.1780400406","article-title":"Immunogenetic similarities between patients with Felty's syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis","volume":"40","author":"Starkebaum","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0028","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MOH.0b013e32834760fb","article-title":"The spectrum of large granular lymphocyte leukemia and Felty's syndrome","volume":"18","author":"Liu","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0029","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3324\/haematol.2017.175729","article-title":"Somatic STAT3 mutations in Felty syndrome: an implication for a common pathogenesis with large granular lymphocyte leukemia","volume":"103","author":"Savola","year":"2018","journal-title":"Hematologica"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0030","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jmoldx.2020.04.213","article-title":"Next-generation sequencing in high-sensitive detection of mutations in tumors: challenges, advances, and applications","volume":"22","author":"Singh","year":"2020","journal-title":"J Mol Diagnostics"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0031","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1182\/blood-2013-05-506386","article-title":"Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapes","volume":"122","author":"Clemente","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0032","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1182\/bloodadvances.2018027862","article-title":"Subclonal STAT3 mutations solidify clonal dominance","volume":"3","author":"Kerr","year":"2019","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0033","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2249.1995.tb02271.x","article-title":"Large granular lymphocyte expansions in patients with Felty's syndrome: analysis using anti-T cell receptor V beta-specific monoclonal antibodies","volume":"101","author":"Bowman","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0034","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-018-0107-2","article-title":"Clonal hematopoiesis in patients with rheumatoid arthritis","volume":"8","author":"Savola","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0035","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/art.40654","article-title":"Prevalence and characteristics of persistent clonal T-LGL expansions in rheumatoid arthritis: a comprehensive analysis of 529 patients","volume":"79","author":"Schwaneck","year":"2018","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0036","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.4049\/jimmunol.169.4.1984","article-title":"Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals","volume":"169","author":"Khan","year":"2002","journal-title":"J Immunol"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0037","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/s41467-022-29173-z","article-title":"Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia","volume":"13","author":"Huuhtanen","year":"2022","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0038","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0039","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T cell large granular lymphocyte leukemia","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10875-015-0187-8","article-title":"The ying and yang of STAT3 in human disease","volume":"35","author":"Vogel","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0041","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.20110283","article-title":"Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas","volume":"208","author":"Pilati","year":"2011","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0042","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/07853890.2014.882105","article-title":"Uncovering the pathogenesis of large granular lymphocytic leukemia\u2014novel STAT3 and STAT5b mutations","volume":"46","author":"Rajala","year":"2014","journal-title":"Ann Med"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0043","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/leu.2015.263","article-title":"Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia","volume":"30","author":"Andersson","year":"2016","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0044","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3324\/haematol.2014.113142","article-title":"The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia","volume":"100","author":"Rajala","year":"2015","journal-title":"Hematologica"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0045","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00277-012-1649-1","article-title":"Clonal T-LGL population mimicking leukemia in Felty's syndrome - Part of a continuous spectrum of T-LGL proliferations?","volume":"92","author":"Schrenk","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0046","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00296-020-04757-4","article-title":"Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis","volume":"41","author":"Gorodetskiy","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0047","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1182\/blood-2012-12-474577","article-title":"Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia","volume":"121","author":"Rajala","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0048","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood-2016-06-724856","article-title":"High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia","volume":"128","author":"Andersson","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-022-00630-8","article-title":"Identification of novel STAT5B mutations and characterization of TCR\u03b2 signatures in CD4+ T-cell large granular lymphocyte leukemia","volume":"12","author":"Bhattacharya","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0050","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2014-03-559542","article-title":"Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia","volume":"124","author":"Kiel","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0051","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/leu.2014.89","article-title":"Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia","volume":"28","author":"Kontro","year":"2014","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0052","article-title":"Genomic landscape of TCR Alpha-Beta and TCR Gamma-Delta T-large granular lymphocyte leukemia","author":"Cheon","year":"2022","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0053","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/annrheumdis-2016-210944","article-title":"Early-onset autoimmune disease due to a heterozygous loss-of-function mutation in TNFAIP3 (A20)","volume":"77","author":"Duncan","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0054","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41436-019-0623-x","article-title":"Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals","volume":"22","author":"Margot","year":"2020","journal-title":"Genet Med"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0055","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1182\/blood.2020005844","article-title":"Germline TET2 loss of function causes childhood immunodeficiency and lymphoma","volume":"136","author":"Spegarova","year":"2020","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0056","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.3390\/cancers12123508","article-title":"STAT3 and STAT5B mutations in in T \/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): association with disease features","volume":"12","author":"Munoz-Garcia","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0057","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0058","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0059","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1182\/blood-2013-04-494930","article-title":"STAT3-mutations indicate the presence of subclinical T cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients","volume":"122","author":"Jerez","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0060","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/s41375-021-01231-3","article-title":"Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia","volume":"35","author":"Lundgren","year":"2021","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0061","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/bloodadvances.2018022723","article-title":"Frequent STAT3 mutations in CD8+ T cells from patients with pure red cell aplasia","volume":"2","author":"Kawakami","year":"2018","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0062","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2016.07.018","article-title":"Interleukin-15-Dependent T-Cell-like Innate Intraepithelial Lymphocytes Develop in the Intestine and Transform into Lymphomas in Celiac Disease","volume":"45","author":"Ettersperger","year":"2016","journal-title":"Immunity"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0063","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clim.2016.11.018","article-title":"A novel class of somatic mutations in blood detected preferentially in CD8\u202f+\u202fcells","volume":"175","author":"Valori","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0261002","article-title":"CD8+ cell somatic mutations in multiple sclerosis patients and controls-Enrichment of mutations in STAT3 and other genes implicated in hematological malignancies","volume":"16","author":"Valori","year":"2021","journal-title":"PLoS One"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0065","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3324\/haematol.2021.279140","article-title":"Somatic STAT3 mutations in CD8+ T cells of healthy blood donors carrying human T-cell leukemia virus type 2","volume":"107","author":"Kim","year":"2022","journal-title":"Hematologica"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0066","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jaci.2018.01.012","article-title":"ADA2 deficiency: Clonal lymphoproliferation in a subset of patients","volume":"141","author":"Trotta","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0067","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.3324\/haematol.2019.220889","article-title":"Somatic mutations and T-cell clonality in patients with immunodeficiency","volume":"105","author":"Savola","year":"2020","journal-title":"Hematologica"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0068","doi-asserted-by":"crossref","first-page":"15869","DOI":"10.1038\/ncomms15869","article-title":"Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis","volume":"8","author":"Savola","year":"2017","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0069","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.578848","article-title":"Adult-onset anti-citrullinated peptide antibody-negative destructive rheumatoid arthritis is characterized by a disease-specific CD8+ T lymphocyte signature","volume":"11","author":"Kelkka","year":"2020","journal-title":"Front Immunol"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0070","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s41467-022-29175-x","article-title":"Single-cell RNA sequencing coupled to TCR profiling of large granular lymphocyte leukemia T cells","volume":"13","author":"Gao","year":"2022","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0071","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/S2352-3026(15)00227-6","article-title":"Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study","volume":"3","author":"Dumitriu","year":"2016","journal-title":"Lancet Hematol"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0072","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.stem.2018.01.011","article-title":"Clonal hematopoiesis and evolution to hematopoietic malignancies","volume":"22","author":"Bowman","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0073","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0074","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from Blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0075","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","article-title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","volume":"130","author":"Zink","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0076","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/blood-2017-04-777029","article-title":"DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions","volume":"130","author":"Buscarlet","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0077","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/s41375-018-0047-7","article-title":"Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis","volume":"32","author":"Arends","year":"2018","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0078","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajhg.2017.05.013","article-title":"Ultra-sensitive sequencing identifies high prevalence of clonal hematopoiesis-associated mutations throughout adult life","volume":"101","author":"Acuna-Hidalgo","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0079","doi-asserted-by":"crossref","first-page":"12484","DOI":"10.1038\/ncomms12484","article-title":"Clonal hematopoiesis harboring AML-associated mutations is ubiquitous in healthy adults","volume":"7","author":"Young","year":"2016","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0081","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2018-01-829937","article-title":"Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A","volume":"132","author":"Buscarlet","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0082","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/s41591-021-01521-4","article-title":"Distinction of lymphoid and myeloid clonal hematopoiesis","volume":"27","author":"Niroula","year":"2021","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0083","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0084","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1182\/bloodadvances.2019000770","article-title":"High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential","volume":"4","author":"Busque","year":"2020","journal-title":"Blood Adv"},{"issue":"80-","key":"10.1053\/j.seminhematol.2022.07.004_bib0085","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with Tet2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0086","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","article-title":"CRISPR-mediated gene editing to assess the roles of TET2 and DNMT3A in clonal hematopoiesis and cardiovascular disease","volume":"123","author":"Sano","year":"2018","journal-title":"Circ Res"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0087","first-page":"1","article-title":"Rheumatoid arthritis and lymphoma: Incidence, pathogenesis, biology, and outcome","author":"Klein","year":"2018","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0088","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3324\/haematol.2011.056283","article-title":"Acute myeloid leukemia developing in patients with autoimmune diseases","volume":"97","author":"Ramadan","year":"2012","journal-title":"Hematologica"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0089","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood.2021011320","article-title":"Clinical relevance of clonal hematopoiesis in persons aged \u226580 years","volume":"138","author":"Rossi","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0090","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood.2020010163","article-title":"CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune disease","volume":"138","author":"Hecker","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0091","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fgene.2016.00147","article-title":"DNA damage response and immune defense: Links and mechanisms","volume":"7","author":"Nakad","year":"2016","journal-title":"Front Genet"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0092","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic hematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0093","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0094","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","article-title":"Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells","volume":"558","author":"Fraietta","year":"2018","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0095","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41375-019-0601-y","article-title":"Large granular lymphocytic leukemia coexists with myeloid clones and myelodysplastic syndrome","volume":"34","author":"Durrani","year":"2020","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0096","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1002\/ajh.24586","article-title":"Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential","volume":"92","author":"Raess","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0097","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1182\/blood.2020005831","article-title":"Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias","volume":"138","author":"Olson","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2022.07.004_bib0098","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1182\/blood.2020006721","article-title":"Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells","volume":"137","author":"Pastoret","year":"2021","journal-title":"Blood"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196322000415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196322000415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:28:05Z","timestamp":1758522485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196322000415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0037196322000415"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2022.07.004","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The spectrum of somatic mutations in large granular lymphocyte leukemia, rheumatoid arthritis, and Felty's syndrome","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2022.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}